196 related articles for article (PubMed ID: 37195970)
21. CD4/CD8 Ratio and the Risk of Kaposi Sarcoma or Non-Hodgkin Lymphoma in the Context of Efficiently Treated Human Immunodeficiency Virus (HIV) Infection: A Collaborative Analysis of 20 European Cohort Studies.
Caby F; Guiguet M; Weiss L; Winston A; Miro JM; Konopnicki D; Le Moing V; Bonnet F; Reiss P; Mussini C; Poizot-Martin I; Taylor N; Skoutelis A; Meyer L; Goujard C; Bartmeyer B; Boesecke C; Antinori A; Quiros-Roldan E; Wittkop L; Frederiksen C; Castagna A; Thurnheer MC; Svedhem V; Jose S; Costagliola D; Mary-Krause M; Grabar S;
Clin Infect Dis; 2021 Jul; 73(1):50-59. PubMed ID: 34370842
[TBL] [Abstract][Full Text] [Related]
22. Recrudescent Kaposi's sarcoma after initiation of HAART: a manifestation of immune reconstitution syndrome.
Leidner RS; Aboulafia DM
AIDS Patient Care STDS; 2005 Oct; 19(10):635-44. PubMed ID: 16232048
[TBL] [Abstract][Full Text] [Related]
23. A fatal case of kaposi sarcoma due to immune reconstitution inflammatory syndrome.
Stover KR; Molitorisz S; Swiatlo E; Muzny CA
Am J Med Sci; 2012 May; 343(5):421-5. PubMed ID: 22227511
[TBL] [Abstract][Full Text] [Related]
24. A novel mathematical model of AIDS-associated Kaposi's sarcoma: Analysis and optimal control.
Kaondera-Shava RF; Lungu E; Szomolay B
Biosystems; 2021 Feb; 200():104318. PubMed ID: 33309554
[TBL] [Abstract][Full Text] [Related]
25. Chylous ascites in disseminated Kaposi sarcoma: an unusual manifestation as immune reconstitution inflammatory syndrome.
Cipriano P; Nabais I; Melo N; Alves AR
BMJ Case Rep; 2019 Mar; 12(3):. PubMed ID: 30904896
[TBL] [Abstract][Full Text] [Related]
26. Kaposi sarcoma-induced immune reconstitution syndrome: a case report.
Abdeljaleel F; Azar J; Ayasa LA; Rabaia D
Ann Med Surg (Lond); 2024 Apr; 86(4):2242-2247. PubMed ID: 38576974
[TBL] [Abstract][Full Text] [Related]
27. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
Meintjes G; Stek C; Blumenthal L; Thienemann F; Schutz C; Buyze J; Ravinetto R; van Loen H; Nair A; Jackson A; Colebunders R; Maartens G; Wilkinson RJ; Lynen L;
N Engl J Med; 2018 Nov; 379(20):1915-1925. PubMed ID: 30428290
[TBL] [Abstract][Full Text] [Related]
28. Histological features of kaposi sarcoma in a patient receiving highly active antiviral therapy.
Eng W; Cockerell CJ
Am J Dermatopathol; 2004 Apr; 26(2):127-32. PubMed ID: 15024195
[TBL] [Abstract][Full Text] [Related]
29. Differential impact of combination antiretroviral therapy in preventing Kaposi's sarcoma with and without visceral involvement.
Grabar S; Abraham B; Mahamat A; Del Giudice P; Rosenthal E; Costagliola D
J Clin Oncol; 2006 Jul; 24(21):3408-14. PubMed ID: 16849755
[TBL] [Abstract][Full Text] [Related]
30. Oral HIV-associated Kaposi sarcoma.
Pantanowitz L; Khammissa RA; Lemmer J; Feller L
J Oral Pathol Med; 2013 Mar; 42(3):201-7. PubMed ID: 22672182
[TBL] [Abstract][Full Text] [Related]
31. Pilot study of oral valganciclovir therapy in patients with classic Kaposi sarcoma.
Krown SE; Dittmer DP; Cesarman E
J Infect Dis; 2011 Apr; 203(8):1082-6. PubMed ID: 21450998
[TBL] [Abstract][Full Text] [Related]
32. Disseminated infections due to Immune Reconstitution Inflammatory Syndrome after highly active antiretroviral therapy--report of 3 cases from Nigeria.
Ogoina D; Adekunle V; Obiako R; Umar A; Akolawole M; Ovosi J
Pan Afr Med J; 2011; 9():38. PubMed ID: 22355437
[TBL] [Abstract][Full Text] [Related]
33. Immune reconstitution inflammatory syndrome: incidence and implications for mortality.
Novak RM; Richardson JT; Buchacz K; Chmiel JS; Durham MD; Palella FJ; Wendrow A; Wood K; Young B; Brooks JT;
AIDS; 2012 Mar; 26(6):721-30. PubMed ID: 22233655
[TBL] [Abstract][Full Text] [Related]
34. Localization of human herpesvirus type 8 (HHV-8) in the Kaposi's sarcoma tissues and the semen specimens of HIV-1 infected and uninfected individuals by utilizing in situ polymerase chain reaction.
Bobroski L; Bagasra AU; Patel D; Saikumari P; Memoli M; Abbey MV; Wood C; Sosa C; Bagasra O
J Reprod Immunol; 1998 Dec; 41(1-2):149-60. PubMed ID: 10213307
[TBL] [Abstract][Full Text] [Related]
35. Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma.
Bower M; Nelson M; Young AM; Thirlwell C; Newsom-Davis T; Mandalia S; Dhillon T; Holmes P; Gazzard BG; Stebbing J
J Clin Oncol; 2005 Aug; 23(22):5224-8. PubMed ID: 16051964
[TBL] [Abstract][Full Text] [Related]
36. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
Cochrane Database Syst Rev; 2014 Aug; 8(8):CD003256. PubMed ID: 25221796
[TBL] [Abstract][Full Text] [Related]
37. Predictors of immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma: a case report.
Cattelan AM; Mattiolo A; Grassi A; Piano MA; Sasset L; Trevenzoli M; Zanovello P; Calabrò ML
Infect Agent Cancer; 2016; 11():5. PubMed ID: 26848307
[TBL] [Abstract][Full Text] [Related]
38. Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy.
Simonetti FR; Ricaboni D; Cattaneo D; Micheli V; Rusconi S; Gervasoni C
J Clin Virol; 2016 Jan; 74():75-7. PubMed ID: 26682615
[TBL] [Abstract][Full Text] [Related]
39. Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults.
Gbabe OF; Okwundu CI; Dedicoat M; Freeman EE
Cochrane Database Syst Rev; 2014; (9):CD003256. PubMed ID: 25313415
[TBL] [Abstract][Full Text] [Related]
40. Valganciclovir for suppression of human herpesvirus-8 replication: a randomized, double-blind, placebo-controlled, crossover trial.
Casper C; Krantz EM; Corey L; Kuntz SR; Wang J; Selke S; Hamilton S; Huang ML; Wald A
J Infect Dis; 2008 Jul; 198(1):23-30. PubMed ID: 18491970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
